JP2019519484A5 - - Google Patents

Download PDF

Info

Publication number
JP2019519484A5
JP2019519484A5 JP2018557818A JP2018557818A JP2019519484A5 JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5 JP 2018557818 A JP2018557818 A JP 2018557818A JP 2018557818 A JP2018557818 A JP 2018557818A JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5
Authority
JP
Japan
Prior art keywords
acetamide
pyrazol
sulfamoylphenyl
chlorophenyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557818A
Other languages
English (en)
Japanese (ja)
Other versions
JP7033079B2 (ja
JP2019519484A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/059882 external-priority patent/WO2017191000A1/en
Publication of JP2019519484A publication Critical patent/JP2019519484A/ja
Publication of JP2019519484A5 publication Critical patent/JP2019519484A5/ja
Priority to JP2021198484A priority Critical patent/JP7104232B2/ja
Application granted granted Critical
Publication of JP7033079B2 publication Critical patent/JP7033079B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557818A 2016-05-03 2017-04-26 芳香族スルホンアミド誘導体 Active JP7033079B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021198484A JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167996.4 2016-05-03
EP16167996 2016-05-03
PCT/EP2017/059882 WO2017191000A1 (en) 2016-05-03 2017-04-26 Aromatic sulfonamide derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021198484A Division JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Publications (3)

Publication Number Publication Date
JP2019519484A JP2019519484A (ja) 2019-07-11
JP2019519484A5 true JP2019519484A5 (enExample) 2020-06-11
JP7033079B2 JP7033079B2 (ja) 2022-03-09

Family

ID=55910814

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018557818A Active JP7033079B2 (ja) 2016-05-03 2017-04-26 芳香族スルホンアミド誘導体
JP2021198484A Active JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021198484A Active JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Country Status (42)

Country Link
US (2) US10844016B2 (enExample)
EP (2) EP3458443B1 (enExample)
JP (2) JP7033079B2 (enExample)
KR (1) KR102388962B1 (enExample)
CN (3) CN115054600B (enExample)
AR (1) AR108356A1 (enExample)
AU (1) AU2017260125B2 (enExample)
CL (1) CL2018003135A1 (enExample)
CO (1) CO2018011935A2 (enExample)
CR (1) CR20180528A (enExample)
CU (1) CU24516B1 (enExample)
CY (1) CY1123801T1 (enExample)
DK (1) DK3458443T3 (enExample)
DO (1) DOP2018000241A (enExample)
EA (1) EA201892450A1 (enExample)
EC (1) ECSP18082774A (enExample)
ES (1) ES2829270T3 (enExample)
GE (2) GEAP202114943A (enExample)
HR (1) HRP20201746T1 (enExample)
HU (1) HUE051348T2 (enExample)
IL (1) IL262580B (enExample)
JO (1) JOP20170107B1 (enExample)
LT (1) LT3458443T (enExample)
MA (1) MA45020B1 (enExample)
MX (1) MX382068B (enExample)
MY (1) MY187845A (enExample)
NI (1) NI201800116A (enExample)
PE (1) PE20190913A1 (enExample)
PH (1) PH12018502307A1 (enExample)
PL (1) PL3458443T3 (enExample)
PT (1) PT3458443T (enExample)
RS (1) RS61012B1 (enExample)
SA (1) SA518400371B1 (enExample)
SG (1) SG11201809126RA (enExample)
SI (1) SI3458443T1 (enExample)
SV (1) SV2018005778A (enExample)
TN (1) TN2018000369A1 (enExample)
TW (1) TWI723158B (enExample)
UA (1) UA122819C2 (enExample)
UY (1) UY37224A (enExample)
WO (1) WO2017191000A1 (enExample)
ZA (1) ZA201808130B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3458443B1 (en) * 2016-05-03 2020-08-19 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives
EP3529246B1 (en) * 2016-10-24 2023-10-18 FMC Corporation Oxadiazoles having fungicidal activity
WO2018104307A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
WO2018210729A1 (en) * 2017-05-18 2018-11-22 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor
JOP20190278A1 (ar) * 2017-05-31 2019-11-28 Novartis Ag مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية
KR20200081445A (ko) * 2017-10-29 2020-07-07 바이엘 악티엔게젤샤프트 허혈성 졸중의 치료를 위한 방향족 술폰아미드 유도체
IL279810B2 (en) 2018-08-31 2025-03-01 Xenon Pharmaceuticals Inc Heteroaryl-modified sulfonamide compounds and their use as medicinal agents
AU2020390377B2 (en) * 2019-11-29 2023-12-21 Wuhan Ll Science And Technology Development Co., Ltd. Compound containing benzene ring and application thereof
CN113082023B (zh) * 2019-12-23 2024-03-01 武汉朗来科技发展有限公司 P2x3抑制剂和p2x4抑制剂的药物组合及其应用
US20230118751A1 (en) * 2019-12-30 2023-04-20 Wuhan Ll Science And Technology Development Co., Ltd. Fused ring compound and application thereof
AU2021301158A1 (en) 2020-06-30 2022-12-15 Bayer Aktiengesellschaft Use of N-phenylacetamides having P2X4 receptor antagonistic activity for treating certain ocular disorders
CN115996911A (zh) 2020-06-30 2023-04-21 拜耳公司 具有p2x4受体拮抗活性的取代的n-苯乙酰胺
CN111743864B (zh) * 2020-08-05 2022-04-01 牡丹江医学院 一种体育外伤喷雾剂及其制备方法
WO2022049253A1 (en) 2020-09-07 2022-03-10 Bayer Aktiengesellschaft Substituted n-heteroaryl-n-pyridinylacetamides as p2x4 modulators
WO2022161416A1 (zh) * 2021-01-27 2022-08-04 武汉朗来科技发展有限公司 一种芳香化合物、其制备方法及应用
CN116917276A (zh) 2021-03-01 2023-10-20 日本农药株式会社 具有磺酰胺基的缩合杂环化合物或其盐类及含有该化合物或其盐类的农业园艺用杀虫剂或者动物用的外部或内部寄生虫防除剂以及其使用方法
US20240239786A1 (en) * 2021-04-12 2024-07-18 Yale University Compositions and methods for the treatment and prevention of cancer
US11878269B2 (en) 2022-03-17 2024-01-23 International Business Machines Corporation Cyclopropeneimines for capture and transfer of carbon dioxide
US11975290B2 (en) 2022-03-17 2024-05-07 International Business Machines Corporation Cyclopropeneimines for capture and transfer of carbon dioxide
CN119233829A (zh) 2022-03-31 2024-12-31 学校法人高崎健康福祉大学 用于预防、抑制或治疗伴随假性过敏反应的症状的医药组合物
US12415889B2 (en) 2022-08-19 2025-09-16 International Business Machines Corporation Cyclopropenimines for activation of carbon dioxide
US12478951B2 (en) 2022-08-19 2025-11-25 International Business Machines Corporation Cyclopropenimines for activation of carbon dioxide
US12479793B2 (en) 2022-08-19 2025-11-25 International Business Machines Corporation Cyclopropenimines for mineralization of carbon dioxide
AU2024303437A1 (en) 2023-06-16 2026-01-15 Wuhan Createrna Science And Technology Co., Ltd. Solid dispersion of p2x4 inhibitor, and preparation method therefor and use thereof
WO2025051851A1 (en) 2023-09-05 2025-03-13 Bayer Aktiengesellschaft Pharmaceutical dosage forms comprising 2-(2-chlorophenyl)-n-[4-(4-cyano-1h-pyrazol-1-yl)-3-sulfamoylphenyl]acetamide

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5994398A (en) * 1996-12-11 1999-11-30 Elan Pharmaceuticals, Inc. Arylsulfonamides as phospholipase A2 inhibitors
EP3575288B1 (en) * 2009-09-03 2021-10-27 Bristol-Myers Squibb Company Quinazolines as potassium ion channel inhibitors
US20130023534A1 (en) 2010-03-26 2013-01-24 Casillas Linda N Pyrazolyl-pyrimidines as kinase inhibitors
ES2715611T3 (es) 2010-05-17 2019-06-05 Incozen Therapeutics Pvt Ltd Compuestos novedosos de 3H-imidazo[4,5-b]piridina-3,5-disustituida y 3H-[1,2,3]triazolo[4,5-b]piridina 3,5-disustituida como moduladores de proteína cinasas
CN103080094B (zh) * 2010-07-13 2015-06-24 日本化学医药株式会社 P2x4受体拮抗剂
AU2013208536B2 (en) 2012-01-13 2017-07-20 Nippon Chemiphar Co., Ltd. P2X4 receptor antagonist
US9872822B2 (en) * 2013-06-21 2018-01-23 L'oreal Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition
EP3564217B1 (en) * 2013-07-12 2021-01-27 Nippon Chemiphar Co., Ltd. P2x4 receptor antagonist
US9873683B2 (en) 2013-07-12 2018-01-23 Nippon Chemiphar Co., Ltd P2X4 receptor antagonist
WO2015088565A1 (en) 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds and methods of use thereof
WO2015088564A1 (en) 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds
US20180338980A1 (en) * 2015-06-10 2018-11-29 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
US12220420B2 (en) 2016-05-03 2025-02-11 Galera Labs, Llc Combination therapy for cancer treatment
EP3458443B1 (en) 2016-05-03 2020-08-19 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives
WO2018104307A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
WO2018104305A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Field of application of the invention
WO2018210729A1 (en) * 2017-05-18 2018-11-22 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor
KR20200081445A (ko) * 2017-10-29 2020-07-07 바이엘 악티엔게젤샤프트 허혈성 졸중의 치료를 위한 방향족 술폰아미드 유도체

Similar Documents

Publication Publication Date Title
JP2019519484A5 (enExample)
HRP20201746T1 (hr) Aromatski derivati sulfonamida
JP2019504821A5 (enExample)
JP2016523911A5 (enExample)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2017500364A5 (enExample)
US20090253676A1 (en) Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
JP2014527959A5 (enExample)
JP2014525444A5 (enExample)
JP2019530667A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
JP2018524331A5 (enExample)
HRP20191140T1 (hr) Spojevi i pripravci kao inhibitori c-kit kinaze
ME02856B (me) Aminopirimidinilni spojevi kao inhibitori jak
JP2011518836A5 (enExample)
JP2015522002A5 (enExample)
IL306126A (en) Heterocyclic compounds
JP2016510035A5 (enExample)
JP2014525448A5 (enExample)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2017512794A5 (enExample)
JP2010510319A5 (enExample)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
HRP20200440T1 (hr) 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori
JP2016518344A5 (enExample)